Fujiko Oh-hashi

454 total citations
22 papers, 382 citations indexed

About

Fujiko Oh-hashi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Fujiko Oh-hashi has authored 22 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Fujiko Oh-hashi's work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (5 papers) and Cancer Research and Treatments (4 papers). Fujiko Oh-hashi is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (5 papers) and Cancer Research and Treatments (4 papers). Fujiko Oh-hashi collaborates with scholars based in Japan, United States and Singapore. Fujiko Oh-hashi's co-authors include Tateshi Kataoka, Yoshio Sakurai, Jeffrey S. Johnston, Tomoko Oh‐hara, Wan Yong Feng, Kenneth Chun‐Ho Chan, Takashi Tsuruo, Imad Naasani, Shigeru Tsukagoshi and Yasuji Suhara and has published in prestigious journals such as Cancer Immunology Immunotherapy, Cancer Chemotherapy and Pharmacology and Anti-Cancer Drugs.

In The Last Decade

Fujiko Oh-hashi

22 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fujiko Oh-hashi Japan 10 132 123 78 78 70 22 382
Hasan Mukhtar United States 9 229 1.7× 62 0.5× 114 1.5× 156 2.0× 69 1.0× 9 593
Mercedes Nocito Spain 9 117 0.9× 140 1.1× 53 0.7× 45 0.6× 42 0.6× 14 447
Naftali Presser United States 10 172 1.3× 64 0.5× 130 1.7× 57 0.7× 52 0.7× 12 405
Astrid Bernhaus Austria 9 193 1.5× 46 0.4× 34 0.4× 61 0.8× 35 0.5× 9 362
Viviana Roman Romania 11 205 1.6× 66 0.5× 53 0.7× 72 0.9× 37 0.5× 21 417
Man Sub Kim South Korea 15 240 1.8× 159 1.3× 60 0.8× 199 2.6× 49 0.7× 24 584
K Gomi Japan 13 164 1.2× 16 0.1× 79 1.0× 52 0.7× 43 0.6× 28 405
Ya‐Jia Xie Macao 12 294 2.2× 116 0.9× 72 0.9× 147 1.9× 36 0.5× 20 612
Iwona Radziejewska Poland 10 212 1.6× 117 1.0× 22 0.3× 38 0.5× 41 0.6× 38 353
Sophia Magkouta Greece 14 189 1.4× 89 0.7× 17 0.2× 91 1.2× 32 0.5× 27 525

Countries citing papers authored by Fujiko Oh-hashi

Since Specialization
Citations

This map shows the geographic impact of Fujiko Oh-hashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujiko Oh-hashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujiko Oh-hashi more than expected).

Fields of papers citing papers by Fujiko Oh-hashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fujiko Oh-hashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujiko Oh-hashi. The network helps show where Fujiko Oh-hashi may publish in the future.

Co-authorship network of co-authors of Fujiko Oh-hashi

This figure shows the co-authorship network connecting the top 25 collaborators of Fujiko Oh-hashi. A scholar is included among the top collaborators of Fujiko Oh-hashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fujiko Oh-hashi. Fujiko Oh-hashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naasani, Imad, Fujiko Oh-hashi, Tomoko Oh‐hara, et al.. (2003). Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.. PubMed. 63(4). 824–30. 173 indexed citations
2.
Shimizu, Motomu, Fujiko Oh-hashi, Shigeru Tsukagoshi, Takao Iwaguchi, & Tateshi Kataoka. (1995). In vitro and in vivo antitumor activity of the interferon inducer bropirimine. Anti-Cancer Drugs. 6(1). 158–162. 6 indexed citations
3.
Kataoka, Tateshi, Kazuhito Honjo, Fujiko Oh-hashi, Nobuo Murayama, & Yasuji Suhara. (1990). Antitumor Activity of T Cells in Lymphoid Organs Induced by Interferon in Tumor-Bearing Mice. Journal of Interferon Research. 10(2). 161–171. 2 indexed citations
4.
Kataoka, Tateshi & Fujiko Oh-hashi. (1985). Non-cytotoxic activity of pyran copolymer-induced macrophages associated with potentiation of tumour vaccine in recipient mice. Cancer Immunology Immunotherapy. 20(1). 69–74. 2 indexed citations
5.
Kataoka, Tateshi, Naomi Matsuura, Fujiko Oh-hashi, & Yasuji Suhara. (1985). Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.. PubMed. 45(8). 3548–53. 35 indexed citations
6.
Kataoka, Tateshi & Fujiko Oh-hashi. (1985). Suppressor macrophages in tumor-bearing mice and their selective inhibition by 6-mercaptopurine.. PubMed. 45(5). 2139–44. 6 indexed citations
7.
Kataoka, Tateshi & Fujiko Oh-hashi. (1985). Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.. PubMed. 45(7). 2962–6. 9 indexed citations
8.
Kataoka, Tateshi, et al.. (1984). Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy.. PubMed. 44(12 Pt 1). 5661–5. 11 indexed citations
9.
Kataoka, Tateshi, Fujiko Oh-hashi, & Yoshio Sakurai. (1984). Enhancement of antiproliferation activity of vincristine and adriamycin by interferon.. PubMed. 75(6). 548–56. 8 indexed citations
10.
Kataoka, Tateshi, Fujiko Oh-hashi, & Yoshio Sakurai. (1982). Identification of effector T cells responsible for enhanced antitumor immunity induced by tumor vaccine and pyran copolymer. Cancer Immunology Immunotherapy. 12(3). 2 indexed citations
11.
Kataoka, Tateshi, Fujiko Oh-hashi, Yoshio Sakurai, & N Ida. (1982). Characteristics of in vitro antiproliferation activity of human interferon-?. Cancer Chemotherapy and Pharmacology. 9(2). 75–80. 19 indexed citations
12.
Kataoka, Tateshi, Fujiko Oh-hashi, & Yoshio Sakurai. (1982). Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A.. PubMed. 73(2). 193–205. 14 indexed citations
13.
Kataoka, Tateshi, et al.. (1981). Effect of antineoplastic agents on the induction of suppressor macrophages by concanavalin A-bound tumor vaccine.. PubMed. 41(12 Pt 1). 5151–7. 4 indexed citations
14.
Kataoka, Tateshi, Fujiko Oh-hashi, Yoshio Sakurai, & Katsushige Gomi. (1980). In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.. PubMed. 40(10). 3832–8. 6 indexed citations
15.
Kataoka, Tateshi, Fujiko Oh-hashi, & Yoshio Sakurai. (1979). Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(7 Pt 1). 2807–10. 15 indexed citations
16.
Kataoka, Tateshi, Fujiko Oh-hashi, Yoshio Sakurai, Masami Okabe, & K Gomi. (1979). Factors responsible for immune resistance to L1210 murine leukemia in hyperimmune mice. Cancer Immunology Immunotherapy. 7(2). 6 indexed citations
17.
Kataoka, Tateshi, Fujiko Oh-hashi, & Yoshio Sakurai. (1979). Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity.. PubMed. 70(2). 155–64. 7 indexed citations
18.
Oh-hashi, Fujiko, Tateshi Kataoka, & Shigeru Tsukagoshi. (1978). Effect of combined use of anticancer drugs with a polysaccharide preparation, Krestin, on mouse leukemia P388.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 69(2). 255–7. 10 indexed citations
19.
Kataoka, Tateshi, Fujiko Oh-hashi, Shigeru Tsukagoshi, & Yoshio Sakurai. (1977). Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor.. PubMed. 37(12). 4416–9. 12 indexed citations
20.
Kataoka, Tateshi, Fujiko Oh-hashi, Shigeru Tsukagoshi, & Yoshio Sakurai. (1977). Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.. PubMed. 37(4). 964–8. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hasan Mukhtar Breakdown of academic impact, for papers by Mercedes Nocito Breakdown of academic impact, for papers by Naftali Presser Breakdown of academic impact, for papers by Astrid Bernhaus Breakdown of academic impact, for papers by Viviana Roman Breakdown of academic impact, for papers by Man Sub Kim Breakdown of academic impact, for papers by K Gomi Breakdown of academic impact, for papers by Ya‐Jia Xie Breakdown of academic impact, for papers by Iwona Radziejewska Breakdown of academic impact, for papers by Sophia Magkouta
Rankless by CCL
2026